NO2018033I1 - Varicella Zoster Virus (VZV) glykoproteinE (gE) - krav 1 i NO 341841 - Google Patents

Varicella Zoster Virus (VZV) glykoproteinE (gE) - krav 1 i NO 341841

Info

Publication number
NO2018033I1
NO2018033I1 NO2018033C NO2018033C NO2018033I1 NO 2018033 I1 NO2018033 I1 NO 2018033I1 NO 2018033 C NO2018033 C NO 2018033C NO 2018033 C NO2018033 C NO 2018033C NO 2018033 I1 NO2018033 I1 NO 2018033I1
Authority
NO
Norway
Prior art keywords
glycoproteine
vzv
zoster virus
varicella zoster
varicella
Prior art date
Application number
NO2018033C
Other languages
English (en)
Original Assignee
Glaxosmithkline Biologicals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa
Priority to NO2018033C priority Critical patent/NO2018033I1/no
Publication of NO2018033I1 publication Critical patent/NO2018033I1/no

Links

NO2018033C 2018-09-20 2018-09-20 Varicella Zoster Virus (VZV) glykoproteinE (gE) - krav 1 i NO 341841 NO2018033I1 (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO2018033C NO2018033I1 (no) 2018-09-20 2018-09-20 Varicella Zoster Virus (VZV) glykoproteinE (gE) - krav 1 i NO 341841

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO2018033C NO2018033I1 (no) 2018-09-20 2018-09-20 Varicella Zoster Virus (VZV) glykoproteinE (gE) - krav 1 i NO 341841

Publications (1)

Publication Number Publication Date
NO2018033I1 true NO2018033I1 (no) 2018-09-20

Family

ID=63720422

Family Applications (1)

Application Number Title Priority Date Filing Date
NO2018033C NO2018033I1 (no) 2018-09-20 2018-09-20 Varicella Zoster Virus (VZV) glykoproteinE (gE) - krav 1 i NO 341841

Country Status (1)

Country Link
NO (1) NO2018033I1 (no)

Similar Documents

Publication Publication Date Title
IL261650A (en) Elimination of hepatitis b virus with antiviral agents
ES2972512T3 (es) Compuestos de aminoácido y métodos de uso
DK3590942T3 (da) Hepatitis B-virusoverfladeantigeninhibitor
DK3269370T3 (da) Hidtil ukendt kondenseret pyrimidinforbindelse eller salt deraf
DK3345907T3 (da) Pyrazolo[3,4-d]pyrimidinforbindelser eller salte deraf
IL278892A (en) Varicella-zoster virus antigen variant and its use
KR20180084865A (ko) 적응형 광원
DK3193931T3 (da) Neutralisering af hæmmende veje i lymfocytter
IL245312B (en) Recombinant oncolytic herpes simplex virus
IL265166B (en) pyrimidine derivatives
DK3400659T3 (da) Dæmpning af optisk interferens inden for båndet til optiske kommunikationssystemer med direkte detektering
DK3289832T3 (da) Opgradering af lyskilde
ITUB20161190A1 (it) Calcio di fucile con nasello intercambiabile
BR112017024613A2 (pt) Processos e intermediários para a preparação de {1-(etilsulfonil)-3-[4-(7h-pirrolo[2,3-d] pirimidin-4-il)- 1h-pirazol-1-il]azetidin-3-il}acetonitrila
DK3222529T3 (da) Optimering af rækkevidden af et luftfartøjsdockingsystem
UY35654A (es) Dihidroquinoxalinonas y dihidropiridopirazinonas modificadas como inhibidores de la proteína bet
DK3833662T3 (da) Inhibitorer af protein-protein-interaktionen mellem KEAP-1-NRF2-
EP3113801A4 (en) Recombinant herpes simplex virus 2 (hsv-2) vaccine vectors
CR20170005A (es) Derivados de insoindolina
EA202190974A1 (ru) Противовирусные пролекарства и их наносоставы
DK3584654T3 (da) Hierarkisk fordelt ledger
GB201504251D0 (en) Oncolytic herpes simplex virus infected cells
DK3469071T3 (da) Herpesvirus med modificeret glycoprotein D
DK3818047T3 (da) Hidtil ukendte forbindelser til bekæmpelse af arthropoder
NO2018033I1 (no) Varicella Zoster Virus (VZV) glykoproteinE (gE) - krav 1 i NO 341841